Daybu (trofinetide), marketed as Daybue and Daybue Stix in the U.S., could become the first treatment for Rett syndrome neurobehavioral issues in the European Union, if the European Commission approves a committee’s recommendation. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive…
Discussion
My daughter Abby, who has Rett syndrome, won’t sit through a lot of movies, but one she has watched a zillion times is “Harry Potter and the Sorcerer’s Stone,” the first Harry Potter film, which came out in 2001, when Abby was 4. My wife and I think she…
Discussion
My husband, Billy, loves to golf. After working hard all week, there is nothing he enjoys more than spending a few hours on the golf course. These days, I don’t mind how much time he spends golfing. In fact, I encourage it. But it wasn’t always that way. When our…
Discussion
All 12 girls and women with Rett syndrome given the gene therapy candidate TSHA-102 in a clinical trial gained or regained at least one developmental milestone within one year, with consistent responses seen across differing ages and disease severity levels, new trial data show. Longer-term follow‑up data from Part…
Rett syndrome is a rare genetic disorder that mostly affects females. The disease is characterized by normal early development, followed by slowed growth and a loss of motor control. Learn more about the disease here.
Most cases are caused by a mutation in the MECP2 gene. Scientists have identified mutations in CDKL5 and FOXG1 genes in those who have atypical or congenital Rett. Learn more about what causes the disease here.
Rett syndrome is associated with problems in cognitive, sensory, emotional, and motor skills, and across the nervous system that controls involuntary (or autonomic) functions. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
